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ABSTRACT
Background: The conformability of the stent, defined as the 
adaptation of the prosthesis to the natural shape of the vessel, 
is the major cause of geometrical changes after stenting and is 
influenced by the stent material and design. It may be assessed 
by measuring changes in the curvature and the angulation of 
the treated segment after stent implantation. The objective of 
this study was to compare changes in coronary angulation 
after implantation of the bioresorbable vascular scaffold (BVS) 
and cobalt-chromium and stainless steel metal platforms used 
in second-generation drug-eluting stents. Methods: In this 
retrospective analysis, 50 patients with single de novo lesions 
in native coronary arteries and diameter between 2.5 and 
3.5 mm and length up to 23 mm were included. Twenty-five 
patients were treated with BVS and 25 patients were treated 
with cobalt-chromium (n = 12) or stainless steel (n = 13) 
platforms. Angulation was measured using a dedicated quantita-
tive angiography analysis software. Results: Vessel angulation 
significantly changed after device implantation. In the group 
submitted to the implantation of metal platforms there was 
greater coronary angulation change when compared to the 
group treated with BVS (41.6% vs. 14.9%; P < 0.01). When 
we analyzed the performance of the BVS and the different 
metal platforms, coronary angulation change was greater for 
the stainless steel platforms, followed by cobalt-chromium 
platforms and the BVS (53.7% vs. 28.5% vs. 14.9%; P < 
0.01). Conclusions: In this preliminary assessment, the BVS 
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RESUMO
Modificações na Angulação Coronária Após Implante 
de Suporte Vascular Bioabsorvível e de Stents de 
Cromo-Cobalto e Aço Inoxidável
Introdução: A conformabilidade do stent, definida como a 
adaptação da prótese à forma natural do vaso, é a principal 
responsável pelas alterações geométricas produzidas após o 
implante do dispositivo, sendo influenciada pelo material e 
pelo desenho do stent. Ela pode ser a ferida medindo-se as 
modificações da curvatura e a angulação do segmento tra-
tado após o implante do stent. O objetivo deste estudo foi 
comparar as mudanças na angulação coronária após implante 
do suporte vascular bioabsorvível (SVB) e das plataformas 
metálicas de cromo-cobalto e aço inoxidável, utilizada sem 
stents farmacológicos de segunda geração. Métodos: Foram 
incluídos, nesta análise retrospectiva, 50 pacientes com lesões 
únicas, de novo, em coronárias nativas, com diâmetro entre 
2,5 e 3,5 mm e extensão de até 23 mm. Vinte e cinco pacien-
tes foram tratados com SVB e 25 pacientes com plataformas 
metálicas de cromo-cobalto (n = 12) ou de aço inoxidável 
(n = 13). A angulação foi medida usando um software de 
angiografia coronária quantitativa dedicada. Resultados: A 
angulação do vaso modificou-se significativamente após o 
implante dos dispositivos. No grupo submetido ao implante 
de plataformas metálicas, houve maior modificação do ângulo 
coronário quando comparado ao tratado com SVB (41,6% vs. 
14,9%; P < 0,01). Quando observado o comportamento do 
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produced a smaller coronary angulation change. The clinical 
impact of this finding must be prospectively investigated in a 
larger and more complex cohort.
 
 
 
 
 
DESCRIPTORS: Coronary vessels. Stents. Absorbable implants..
Study devices
ABSORB® BVS is a balloon-expandable device 
comprising a polymeric scaffold of poly-L-lactic acid 
(PPLA), covered by a thin layer of amorphous matrix 
of poli-D, L-lactic acid containing 100 µm2 of evero-
limus. The rods of this device are 150 µm thick, and 
its cells have a zigzag format, interconnected by three 
longitudinal bridges. Although radio transparent, this 
BVS has a tag of platinum on each end, which allows 
for the angiographic viewing of its boundaries. Xience 
V® stent consists of a platform of cobalt-chrome with 
biocompatible fluoropolymer and with everolimus at 
a concentration of 100 µm2, with a rod thickness of 
81 µm, associated with a polymer thickness of 7.6 
µm. Otherwise, BioMatrix® stent has a stainless steel 
platform and rods with a thickness of 112 µm covered 
with a biodegradable polymer of polylactic acid (PLA) 
containing biolimus A9 (15.6 µg/cm).
Procedure
The lesions were treated with standard intervention 
techniques, which included an obligatory pre-dilation 
with a shorter balloon and with a diameter 0.5 mm 
smaller than the device used. The post-dilation, which 
was carried out at the discretion of the surgeon, should 
be performed with noncompliant balloons at least 30% 
shorter than the implanted stent or BVS.
Angiographic analysis
After administration of intracoronary nitroglycerin, 
serial angiographic studies were obtained in two cor-
responding orthogonal projections, at pre- and post-
procedure. An angiographic analysis was performed 
off-line by experienced operators at Instituto Dante 
Pazzanesede Cardiologia, using validated software for 
quantitative coronary analysis (QAngio XA version 7.3; 
Medis – Leiden, the Netherlands). The minimal lumen 
diameter (MLD) and the RD, obtained from an average 
of the proximal and distal 5 mm to the target lesion, 
were used to calculate the stenosis diameter [SD = 
(1 – MLD/RD) × 100]. The acute gain was obtained 
from the difference between MLDs before and after 
the procedure. For the evaluation of angulation, the 
angiographic projection with the least shortening of 
SVB e das diferentes plataformas metálicas, a alteração do 
ângulo coronário foi maior para as plataformas de aço ino-
xidável, seguida das plataformas de cromo-cobalto e os SVB 
(53,7% vs. 28,5% vs. 14,9%; P < 0,01). Conclusões: Nesta 
avaliação preliminar, o SVB produziu uma menor mudança 
da angulação coronária. O impacto clínico deste achado 
necessita ser investigado prospectivamente em uma coorte 
maior e mais complexa.
DESCRITORES: Vasos coronários. Stents. Implantes absorvíveis.
T he rectification of a curved segment of a vessel after stenting can modify the dynamics of blood flow and of the shear stress, and may be responsible 
for changes in the distribution of intra-stent intimal 
hyperplasia.1,2
The conformability of the stent, defined as its adap-
tation to the natural shape of the vessel, is the main 
responsible for the geometrical changes produced after 
stenting,3 and the two main determinants of conforma-
bility are the material and the design of the stent.4,5 This 
factor can be gauged by measuring the curvature and 
angulation of the target segment after stent implanta-
tion. A previous trial demonstrated that bioresorbable 
vascular scaffolds (BVS) have better conformability than 
that stents with metal platforms.6
The present study aimed to compare the changes 
in coronary angulation with a specific methodology for 
patients treated with three different devices: BVS and 
metal platforms of cobalt-chrome and stainless steel, 
used in second-generation drug-eluting stents.
METHODS
This is a retrospective, single-center trial conducted 
at the Department of Invasive Cardiology of Institute 
Dante Pazzanese de Cardiologia, São Paulo, Brazil. The 
population included patients consecutively treated at 
different moments, with ABSORB® BVS (Abbott Vascular 
– Santa Clara, United States), BioMatrix® stent (Biosen-
sors Inc. – Newport Beach, United States), and Xience 
V® stent (Abbott Vascular – Santa Clara, United States), 
as part of local protocols.
In general, the patients included had stable or 
unstable angina, or were asymptomatic with objective 
signs of ischemia, with single de novo lesions in na-
tive coronary arteries with stenosis is between 70 and 
90% (visual estimate) and reference diameters (RDs) 
between 2.5 and 3.5 mm. The maximum permitted 
length of the lesion was 23 mm. Patients with acute 
myocardial infarction < 72 hours, lesions in left main 
coronary artery, ostial lesions, lesions with thrombi, 
lesions with excessive calcification that required 
atheroablative techniques before device implantation, 
and bifurcation lesions with lateral branch > 2.0 mm 
were excluded.
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the vessel and the least overlapping of images was 
used. The angles were obtained using a specific tool, 
a digital compass, attached to the quantitative analysis 
system, which was positioned within the target segment 
at the level of pre-procedure MLD. Then, the angle was 
determined by measuring the inner angle between the 
centered lines drawn on the proximal and distal coronary 
segments adjacent to MLD. The angles of the lesions 
were measured during diastole on the same projections 
before and after the procedure. (Figure)
Statistical analysis
Categorical variables were presented as absolute 
numbers and percentages, whereas continuous variables 
were described as means and standard deviations. Quan-
titative variables were analyzed by the nonparametric 
Mann-Whitney test (two groups) or the Kruskal-Wallis 
test (three groups). The association between categorical 
variables was evaluated by chi-squared or Fisher’s exact 
test. The Spearman correlation was used to determine 
whether there was a correlation between the pre-treatment 
angiographic variables (MLD, RD, SD, lesion length, and 
angle of the lesion) and the relative change between 
the angles before and after the procedure.
RESULTS
The present study evaluated 50 patients undergoing 
elective angioplasty, 25 treated with ABSORB® BVS, 12 with 
cobalt-chrome stent (Xience V®), and 13 with a stainless 
steel stent (BioMatrix®). The clinical characteristics are 
summarized in Table 1. There was no significant difference 
among groups regarding clinical characteristics, except 
for a higher prevalence of prior myocardial infarction 
among those treated with bare-metal stents.
The most often approached target vessel in the group 
treated with BVS was the left anterior descending artery, 
while in the groups treated with metal stents, the most 
often approached vessel was the left circumflex artery 
(P = 0.09). Pre-procedural angiographic analyses showed 
no difference among the groups regarding the varia bles 
analyzed, including the RD of the target vessel and the 
lesion length. After the procedure, patients treated with 
BVS showed smaller MLD and acute gain compared to 
bare-metal stents (Table 2).
The angulation of the vessel changed significantly 
after implantation of the devices (Table 3). In the groups 
undergoing implantation of metal platforms, there was 
a greater relative modification of coronary angle when 
compared to those treated with BVS (41.6% vs. 14.9%; 
P < 0.01). When observed the behavior of BVS and of 
the different metal platforms, the change of the coro-
nary angle was greater for the stainless steel platform, 
followed by the cobalt-chromium platform and BVS 
(53.7% vs. 28.5% vs. 14.9%; P <  0.01). 
The only pre-intervention angiographic variable 
associated with the relative change between angles 
before and after the procedure was the angle of the 
lesion before the intervention (P < 0.01), as shown 
in Table 4.
Figure – Coronary angulation analysis. Values obtained after before and after the stenting, using digital compass attached to the quantitative analysis 
system.
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TABLE 1 
Clinical characteristics
Characteristics
BVS
(n = 25)
Metal 
platforms
(n = 25)
Cobalt-chromium 
platform
(n = 12)
Stainless steel 
platform
(n = 13) P value* P value**
Age, years 56.8 ± 7.0 60.4 ± 8.1 59.8 (10.3) 61 (4.8) 0.16 0.33
Male, n (%) 15 (60) 15 (60) 6 (50.0) 9 (69.2) > 0.99 0.39
Hypertension, n (%) 19 (76) 20 (80) 9 (75) 11 (84.6) > 0.99 0.82
Diabetes mellitus, n (%) 5 (20) 1 (4) 0 1 (7.7) 0.19 0.28
Smoking, n (%) 3 (12) 4 (16) 1 (8.3) 3 (23.1) > 0.99 0.57
Dyslipidemia, n (%) 19 (76) 16 (64) 8 (66.7) 8 (61.5) 0.54 0.66
Previous infarction, n (%) 5 (20) 15 (60) 7 (58.3) 8 (61.5) < 0.01 0.01
* Comparison between BVS and bare-metal stents; ** comparison among BVS and cobalt-chromium and stainless steel platforms.  
BVS = bioresorbable vascular scaffold.
TABLE 2 
Angiographic and procedural characteristics
Characteristics
BVS
(n = 25)
Metal platforms
(n = 25)
Cobalt-chromium 
platform
(n = 12)
Stainless steel 
platform 
(n = 13) P value* P value**
Target vessel, n (%) 0.09 0.24
LADA 13 (52) 7 (28) 3 (25) 4 (30.8)
LCx 4 (16) 11 (44) 5 (41.7) 6 (46.2)
RCA 8 (32) 7 (28) 4 (33.3) 3 (23.1)
Pre-procedure
Lesion length, mm 11.7 ± 4.0 11.6 ± 5.0 10.1 ± 3.4 12.9 ± 5.9 0.54 0.31
Reference diameter, mm 2.62 ± 0.45 2.60 ± 0.41 2.73 ± 0.36 2.49 ± 0.44 0.79 0.34
Minimum luminal 
diameter, mm
0.87 ± 0.32 0.84 ± 0.36 0.90 ± 0.25 0.78 ± 0.44 0.73 0.52
Stenosis diameter, % 66.7 ± 10.5 68.5 ± 11.2 67.0 ± 9.2 70.0 ± 13.0 0.53 0.79
Post-procedure
Minimum luminal 
diameter, mm
2.39 ± 0.31 2.68 ± 0.36 2.66 ± 0.26 2.69 ± 0.45 < 0.01 0.03
Stenosis diameter, % 8.4 ± 4.0 6.9 ± 3.6 8.2 ± 4.2 5.6 ± 2.5 0.17 0.58
Acute gain, mm 1.51 ± 0.41 1.83 ± 0.36 1.76 ± 0.28 1.9 ± 0.42 < 0.01 0.02
* Comparison between BVS and bare-metal stents; ** comparison between BVS and cobalt-chromium and stainless steel platforms.
BVS = bioresorbable vascular scaffold; LADA = left anterior descending artery; LCx = left circumflex artery; RCA = right coronary artery.
TABLE 3 
Modification of angles within and among groups
Device
Pre-treatment 
(grades)
Post-treatment 
(grades)
Absolute change 
(grades)
Relative 
change (%) P value*
BVS 16.5 ± 15.5 13.0 ± 10.0 3.6 ± 10.8 14.9 0.02
Metal platforms 20.2 ± 15.6 11.4 ± 12.7 8.9 ± 9.6 41.6 < 0.01
P value** 0.22 0.32 < 0.01 < 0.01
BVS 16.5 ± 15.6 13.0 ± 10.0 3.6 ± 10.8 14.9 0.02
Cobalt-chromium platform 17.2 ± 17.1 9.8 ± 11.7 7.5 ± 11.7 28.5 0.03
Stainless steel platform 23.0 ± 14.2 12.9 ± 13.9 10.1 ± 7.4 53.7 < 0.01
P valueb 0.14 0.49 < 0.01 < 0.01
* Comparison between pre- and post-treatment values within groups; ** comparison between pre- and post-treatment changes among groups.
BVS = bioresorbable vascular scaffold.
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DISCUSSION
In the present study, it was observed that both the 
metal platforms as BVS significantly changed the angle 
of the lesion after the procedure. In addition, the small-
est angle modification occurs with BVS, followed by 
cobalt-chrome and stainless steel platforms. The only 
angiographic variable associated with a relative change 
between the angles was the angle of the lesion before 
the intervention.
The efficacy and safety of stents depend, in part, 
on their mechanical characteristics. A previous trial, 
which evaluated the mechanical properties of 17 metal 
stents analyzed the traction force between tortuosities, 
flexibility and conformability, and demonstrated that 
these properties depend on the design and material 
of the stent.7 The comparison of the mechanical per-
formance of seven stents showed differences among 
the various platforms, with BioMatrix® stent showing 
less flexibility than Xience V® stent (30.06 N/mm2 and 
25.78 N/mm2, respectively).4 Another trial evaluating the 
conformability of BVS and Xience V® stents observed 
that the bioresorbable platform is more advantageous, 
because the curvature and angle of the treated vessel 
are less altered.
Curved vessels have a greater association with 
turbulent flow and non-uniform distributions of shear 
stress, and the outer curvature of the vessel is subjected 
to stress greater than the inner curvature. Regions with 
low shear stress have been associated with the devel-
opment of a thicker neointimal hyperplasia in both 
bare stainless steel stents2 and drug-eluting stents.8 A 
one-year follow-up of BVS stents showed a restoration 
of coronary anatomy close to that observed before the 
procedure, and with a probable restoration of a more 
physiological pattern of blood flow and of shear stress.9
A study on patients treated with bare-metal stents 
demonstrated that the location of the target lesion in 
a coronary segment with angle > 33.5°, as well as a 
change in coronary angulations > 9.1° after the device 
implantation, were independent predictors of greater 
cardiac events and of restenosis.10 Conversely, a study 
with 289 patients treated with drug-eluting metal stents 
failed to demonstrate an association between coronary 
angulation or vascular geometry modification with the 
occurrence of adverse events (target vessel failure, target 
vessel revascularization, or in-hospital infarction), after 
one year of follow-up.11
The new generations of drug-eluting stents, with 
more flexible alloys, thinner platforms, and better con-
formability, have the ability to change less intensely 
the coronary geometry, compared with older stents. 
Although BVS are superior to current metal stents in 
terms of conformability, and considering that these dif-
ferences are very subtle, studies with more cases and 
with long-term follow-ups are needed to confirm the 
clinical benefits of these findings.
Limitations
As the main limitations of this trial, the authors 
highlight its nonrandomized design, the small popula-
tion included in each group, and the limited complexity 
profile of the lesions.
CONCLUSIONS
In this preliminary evaluation, the implantation of 
everolimus-eluting BVS showed a lesser change in the 
coronary angulation compared to cobalt-chromium and 
stainless steel platforms. For now, the clinical impact 
of this finding is unclear and needs to be prospectively 
investigated in a larger and more complex cohort.
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